High-expression HNRNPA2B1 in endocrine-resistant MCF-7 and LCC9 BC cell lines endows cancer cells with acquired endocrine resistance by activating the Ser/Thr kinase growth factor signaling pathway that regulates its downstream target (141). The gene discussed is HNRNPA2B1; the disease is breast cancer.